Search Results - Kim Linton

Refine Results
  1. 1
    Mantle cell lymphoma – advances in molecular biology, prognostication and treatment approaches

    Mantle cell lymphoma – advances in molecular biology, prognostication and treatment approaches by Elisabeth Silkenstedt, Kim Linton, Martin Dreyling

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    A clinician’s guide to biosimilars in oncology

    A clinician’s guide to biosimilars in oncology by Hope S. Rugo, Kim Linton, P. Cervi, Julie A. Rosenberg, Ira Jacobs

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center

    Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single... by Adam Gibb, C. Jones, Adrian Bloor, S. Kulkarni, Tim Illidge, Kim Linton, John Radford

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma

    Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma by Liezel Griffin, Laura Cove-Smith, Hana Alachkar, John Radford, Rebecca Brooke, Kim Linton

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma

    Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma by Anna Maria Tsakiroglou, Martin Fergie, Ken Oguejiofor, Kim Linton, David Thomson, Peter L. Stern, Susan Astley, Richard Byers, Catharine West

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Guidelines for the management of diffuse large B‐cell lymphoma

    Guidelines for the management of diffuse large B‐cell lymphoma by Sridhar Chaganti, Tim Illidge, Sally F. Barrington, Pam McKay, Kim Linton, Kate Cwynarski, Andrew McMillan, A. J. Davies, Simon Stern, Karl S. Peggs

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma

    Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma by Christopher P. Fox, Elizabeth H. Phillips, Jeffery Smith, Kim Linton, Eve Gallop‐Evans, Claire Hemmaway, Dorothee P. Auer, Charlotte Fuller, Andrew Davies, Pam McKay, Kate Cwynarski

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma

    Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma by Alastair Greystoke, James P.B. O’Connor, Kim Linton, Malcolm Taylor, Jeffrey L. Cummings, Tim Ward, F Maders, Andrew Hughes, Malcolm Ranson, Tim Illidge, John Radford, Caroline Dive

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours

    Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours by Kim Linton, Y. Hey, Edward J. Saunders, Maria Jeziorska, J. Denton, Charles L. Wilson, R. Swindell, Siân Dibben, Crispin Miller, Stuart D Pepper, John Radford, Anthony J. Freemont

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Drug-Induced Interstitial Lung Disease: A Systematic Review

    Drug-Induced Interstitial Lung Disease: A Systematic Review by Sarah Skeoch, Nicholas Weatherley, Andrew J. Swift, Alexander Oldroyd, Christopher Johns, Conal Hayton, Alessandro Giollo, Jim M. Wild, John C. Waterton, Maya H Buch, Kim Linton, Ian N Bruce, C.T. Leonard, Stephen Bianchi, Nazia Chaudhuri

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Initial Findings from a First-in-Human Phase 1a/b Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory B Cell Malignancies

    Initial Findings from a First-in-Human Phase 1a/b Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory B Cell Malignancies by Emma Searle, Francesco Forconi, Kim Linton, Alexey V. Danilov, Pam McKay, David John Lewis, Dima El‐Sharkawi, Mary Gleeson, John C. Riches, Sarah G. Injac, Ted Shih, Srinand Nandakumar, May Tan, Ganesh Cherala, Erin Meredith, Graham P. Collins

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    An Integrated Characterization of Serological, Pathological, and Functional Events in Doxorubicin-Induced Cardiotoxicity

    An Integrated Characterization of Serological, Pathological, and Functional Events in Doxorubicin-Induced Cardiotoxicity by Laura Cove-Smith, Neil Woodhouse, Adam Hargreaves, Jason Kirk, Susan M. Smith, Sally Price, Melanie Galvin, Catherine J. Betts, Simon Brocklehurst, Alison Backen, John Radford, Kim Linton, Ruth Roberts, Matthias Schmitt, Caroline Dive, Jonathan Tugwood, Paul Hockings, Howard R. Mellor

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trial

    Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trial by Michael Northend, William Wilson, Kushani Ediriwickrema, Laura Clifton‐Hadley, Wendi Qian, Zaynab Rana, Tanya-Louise Martin, William Townsend, Moya Young, Fiona Miall, David Cunningham, Jan Walewski, Burhan Ferhanoğlu, Kim Linton, Amanda Johnston, John F. Seymour, David C. Linch, Kirit M. Ardeshna

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study

    Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study by Martin Hutchings, Rogier Mous, Michael Roost Clausen, Peter Johnson, Kim Linton, Martine E.D. Chamuleau, David John Lewis, Anna Sureda, David Cunningham, Roberto S Oliveri, Brian Elliott, Dena DeMarco, Ada Azaryan, Christopher Chiu, Tommy Li, Kuo-mei Chen, Tahamtan Ahmadi, Pieternella J. Lugtenburg

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men

    Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men by Hermann M. Behre, Michael Zitzmann, Richard A. Anderson, David J. Handelsman, Silvia Werdhy Lestari, Robert I. McLachlan, Maria Cristina Meriggiola, M. M. Misro, Gabriela Noé, Frederick C. W. Wu, Mario Festin, Ndema Habib, Kirsten M. Vogelsong, Marianne M. Callahan, Kim Linton, Doug Colvard

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma

    Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma by M. Dreyling, Franck Morschhauser, Krimo Bouabdallah, Dominique Bron, David Cunningham, Sarit Assouline, G. Verhoef, Kim Linton, Catherine Thiéblemont, Umberto Vitolo, Florian Hiemeyer, Marius Giurescu, J. Garcia‐Vargas, Igor Gorbatchevsky, Li Liu, Karl Koechert, Carol Peña, Manoel Martins das Neves, B.H. Childs, Pier Luigi Zinzani

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practice

    Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibili... by Elisabeth Schorb, Christopher P. Fox, Benjamin Kasenda, Kim Linton, Nicolás Martínez‐Calle, Teresa Calimeri, Slavisa Ninkovic, Toby A. Eyre, Tom Cummin, Jeffery Smith, Deborah Yallop, Beatrice De Marco, Mauro Krampera, Stefan Trefz, Lorella Orsucci, Alberto Fabbri, Gerald Illerhaus, Kate Cwynarski, Andrés J.M. Ferreri

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery

    Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery by Matthew R. Wilson, Toby A. Eyre, Nicolás Martínez‐Calle, Matthew J. Ahearne, Katrina Parsons, Gavin Preston, Jahanzaib Khwaja, Jeremy Schofield, Johnathon Elliot, Almurtadha Mula kh, Nimish Shah, Cheuk-Kie Cheung, Matthew A. Timmins, Thomas Creasey, Kim Linton, Jeffery Smith, Christopher P. Fox, Fiona Miall, Kate Cwynarski, Pam McKay

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

    Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and sur... by Nicolás Martínez‐Calle, Edward Poynton, Alia Alchawaf, Shireen Kassam, Matthew Horan, Mark Rafferty, P. Kelsey, Gemma Scott, Dominic Culligan, Hannah Buckley, Yeong Jer Lim, Loretta Ngu, Rory McCulloch, Clare Rowntree, Josh Wright, Pam McKay, Samih Fourali, Toby A. Eyre, Jeffrey A. Smith, Wendy Osborne, Deborah Yallop, Kim Linton, Christopher P. Fox, Kate Cwynarski

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study

    Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study by Stephen Opat, Alessandra Tedeschi, Bei Hu, Kim Linton, Pam McKay, Sophie Leitch, Morton Coleman, Pier Luigi Zinzani, Jie Jin, Mingyuan Sun, Magdalena Sobieraj‐Teague, Peter Browett, Xiaoyan Ke, Catherine Thiéblemont, Kirit M. Ardeshna, Fontanet Bijou, Patricia Walker, Eliza A. Hawkes, Shir‐Jing Ho, Keshu Zhou, Zhiyu Liang, Jianfeng Xu, Chris Tankersley, Richard Delarue, Melannie Co, Judith Trotman

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: